Pre-Open Stock Movers 10/11: (PTGX) (ADMS) (FLXN) Higher; (HYLN) (LUV) (NET) Lower (more...) Oct 11, 2021 09:21AM
Adamas to Present at Upcoming Needham Conference Apr 7, 2021 05:19PM
Companies with NDRs 7/08 Jul 8, 2020 07:25AM
Needham & Company Downgrades Adamas Pharmaceuticals (ADMS) to Hold Mar 5, 2019 07:35AM
Adamas to Present at Two Upcoming Investor Conferences Mar 6, 2018 02:35PM


Mar 28, 2017 10:33AM Adamas to Present at the 16th Annual Needham Healthcare Conference
Jul 19, 2016 12:34PM Needham & Company Reiterates Bullish View on Adamas (ADMS) as FDA Approves Namzaric Label Expansion
Feb 22, 2016 04:05PM Adamas Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
Dec 23, 2015 02:18PM Adamas Pharmaceuticals (ADMS) PT Raised to $38 at Needham & Company
Apr 9, 2015 04:01PM Adamas Pharmaceuticals to Present at 2015 Needham Healthcare Conference
Apr 9, 2015 04:01PM Adamas Pharmaceuticals to Present at 2015 Needham Healthcare Conference
Jun 10, 2014 08:50AM Adamas Pharmaceuticals (ADMS) Bullish Stance Reiterated at Needham & Company as ADS-5102 Moves Into Phase III
May 5, 2014 06:21AM Needham & Company Starts Adamas Pharmaceuticals (ADMS) at Buy
Apr 10, 2014 10:28AM Adamas Pharmaceuticals (ADMS) IPO Opens Higher
Apr 10, 2014 08:44AM Adamas Pharmaceuticals (ADMS) IPO Prices at $16, Low End of Range